Orchard Therapeutics PLC Stock Forecast, Predictions & Price Target

Analyst price target for ORTX

Based on 1 analyst offering 12 month price targets for Orchard Therapeutics PLC.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ORTX stock?

Based on 1 analyst offering ratings for Orchard Therapeutics PLC.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ORTX stock forecasts and price targets.

ORTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 18%
Strong BuyMaintains$15.00+187.08%2023-03-28

1 of 1

ORTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ORTX$5.23$15.00+187.08%Strong Buy
ADAG$1.51$5.00+231.13%Strong Buy
LYRA$2.03$20.00+885.22%Strong Buy

Orchard Therapeutics Stock Forecast FAQ

Is Orchard Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ORTX) stock is to Strong Buy ORTX stock.

Out of 1 analyst, 1 (100%) are recommending ORTX as a Strong Buy, 0 (0%) are recommending ORTX as a Buy, 0 (0%) are recommending ORTX as a Hold, 0 (0%) are recommending ORTX as a Sell, and 0 (0%) are recommending ORTX as a Strong Sell.

If you're new to stock investing, here's how to buy Orchard Therapeutics stock.

What is ORTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ORTX price target, the average ORTX price target is $15.00, with the highest ORTX stock price forecast at $15.00 and the lowest ORTX stock price forecast at $15.00.

The Wall Street analyst predicted that Orchard Therapeutics's share price could reach $15.00 by Mar 28, 2024. The average Orchard Therapeutics stock price prediction forecasts a potential upside of 187.08% from the current ORTX share price of $5.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.